Biggest News Aggregation in the World
📰 Axol Bioscience News

Page 2 - Axol Bioscience News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Axol Bioscience. Real-time updates on events, politics, business and more.

Induced Pluripotent Stem Cell (iPSC) Global Market Report 2023: Sector to Reach $4.36 Billion by 202

DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cell (iPSC) Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global induced pluripotent stem cell (ipsc) market will grow from $2.69 billion in 2022 to $2.97 billion in 2023 at a compound annual growth rate (CAGR) of 10.5...
United States Axol Bioscience Laura Wood National Institute Of Health Astellas Pharma Inc Takara Bio Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Axol Bioscience introduces CiPA-validated human stem cell-derived ventricular cardiomyocytes to help improve drug discovery

Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization services for life science discovery, today announced that its human induced pluripotent stem cell (iPSC)-derived ventricular cardiomyocytes have undergone comprehensive in vitro pro-arrhythmia assay (CiPA) validation.
Axol Bioscience Clyde Biosciences Godfrey Smith Drug Administration Agency Axol Bioscience Ltd Drug Discovery

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science